Archived News

Archived News

News from 2013

AMP Releases White Paper on LDTs - Coins New Term

December 2013: the January 2014 JMD article proposes new, service-oriented terminology - Laboratory Developed Procedures (LDPs). "The new term accurately describes the integral expertise of the clinical laboratory professional," said Andrea Ferreira-Gonzalez, Chair, AMP LDT Working Group.

View the White Paper

View the Press Release

AMP Submits Comments to CMS on MolDX Program

October 2013: Comments detail concerns about the Palmetto Molecular Diagnostics (MolDX) Services Program and Medicare coverage as well as their impact on Gap Fill Pricing for Molecular Pathology Procedures.

View the Comments

AMP Speaks out on Reimbursement Issues

September 2013: In the past four weeks, AMP has submitted comments to the CMS and Palmetto on issues related to reimbursement and patient care. AMP will continue to advocate on behalf of its members and the field of molecular diagnostics.

View the Comments

AMPlifications - View the Most Recent Issue

View the most recent edition of AMPlifications including updates on AMP's education, advocacy, and patient care-related initiatives.

View the Newsletter


June 2013: AMP has joined the Federation of American Societies for Experimental Biology (FASEB). "Being a member of FASEB will enable AMP's voice to be even stronger," said Jennifer L. Hunt, MD, MEd, AMP President.

View the Press Release

AMP v. Myriad - Decision Reached

AMP is very pleased with the Supreme Court’s decision in the case. The Court’s decision that human genes are not patentable is a great step forward for the field of molecular pathology, for genomic science, and most important for our patients. We look forward to exciting future advancements in diagnostic testing and therapeutics that will accrue to the benefit of our patients and our field.

View the Press Release

Link to decision from Supreme Court of the United States:

Professional Societies Delineate Concerns, Offer Recommendations Regarding Interim Pricing for Molecular Tests

May 2013: A coalition representing over 120,000 medical and laboratory professionals and institutions that perform the vast majority of clinical molecular pathology testing in the United States released a joint statement regarding new Medicare prices for those tests.
More Information...

Lung Biomarker Guideline Webcast Now Available

The guideline was developed to establish standards for testing for EGFR and ALK, helping to guide targeted therapies. Pathologists are encouraged to implement the new guideline at their institutions and into their practices to help improve the effectiveness of lung cancer treatment. More information...

View the webcast (wmv file)

Download the slides

AMP Identifies Flaws in AHRQ Report on Genetic Testing

April 2013: The AMP Professional Relations Committee commented on the AHRQ draft report, "Update on Genetic Tests Currently Available for Clinical Use in Common Cancers," identifying methodologic flaws in the data gathering process that have led to gaps in the report's findings.

View the Comments

View the AHRQ Draft Report

Health Information Technology Reform Act Reintroduced in the House

AMP reaffirms its initial comments stating the Act will address this misalignment between the regulations and pathology practice, and AMP wholeheartedly endorses this legislation.

View the Comments

Lung Biomarker Guideline Released by CAP, IASLC, & AMP

The emergence of molecular diagnostic testing in lung cancer offers new hope for patients battling the number one cancer killer in the United States and abroad. Now, for the first time after a decade of biomarker testing in lung cancer, a uniform approach for testing for the EGFR mutation and ALK rearrangement along with the availability of targeted therapies offer lung cancer patients the chance for improved quality of life and more time with their loved ones. More Information...

Download the Guideline now.

AMPlifications - March 2013 Edition

View the most recent newsletter for updates on AMP members and leader's progress in advancing AMP via education, advocacy, and more. View the newsletter.

AMP Cautions FDA on Drug Labeling

March 2013: In a letter to the FDA, Jennifer L. Hunt, AMP President warned, "When the FDA includes a brand name of a diagnostic kit on a drug label, the medical community often views this as a tacit endorsement of that one company's test."

Read the letter.

AMP Commends FDA on Consideration of Alternative Approval Pathways

March 2013: "AMP encourages the FDA to (also) consider how the information describing subpopulations of patients might be described in drug labels," noted Jennifer L. Hunt, AMP President in a letter to the FDA.

Read the letter.

AMP Case Reports in CAP Today

Multilocus Sequencing for Rapid Identification of Molds - the first AMP Case Report was publised in the February issue of CAP Today. More information...

AMP Comments to USPTO on Genetic Diagnostic Testing

January 2013: AMP's comments to USPTO reitterate concern over gene patients potentially interfering with AMP member's ability to deliver optimal care to their patients.

Read the letter.


AMP Comments to CMS Regarding 2013 PFS Final Rule

Read the letter.

Jeffrey A. Kant - AMP Education Fund Established

More Information...

AMP Reports on Possibilities, Challenges, and Applications of Next-Generation Sequencing

View the full Press Release

AMP Mourns the Loss of Jeffrey A. Kant, MD, PhD

Read the obituary.

AMP Supports the TEST Act

Read the letter.

AMP Appeals Breast Cancer Gene Patent Case to U.S. Supreme Court

View the full Press Release

AMP provides comments to CMS Clinical Lab Fee Schedule

Presentation to CMS and additional written comments

Current Issue of AMP News

Read the October 2012 AMP Newsletter

AMP Election Results for 2013

View election results

More than 500 Abstracts Submitted for AMP 2012 Annual Meeting - a 40% increase over last year!

View the full Press Release

AMP Developing a CPT Coding Proposal for Next Gen Sequencing

View the full Press Release

AMP Forms Working Group to Further Consider Oversight of Lab Tests

View the full Press Release

AMP Optimistic in Suit to invalidate Patents on Breast Cancer Genes

March 2012
View the full Press Release

AMP Applauds Supreme Court Ruling: Sees Win for Patients and Personalized Medicine

March 2012
View the full Press Release

AMP Endorses the Health Information Technology Reform Act

March 2012
View the full letter

AMP Requests Moratorium on Human Gene Patenting

February 2012
View the full Press Release
View the full Testimony

AMP Membership Approves New Governance Structure

February 2012
View the full Press Release
View the Strategic Plan

AMP Mourns the Loss of Constance A. Griffin, MD

January 2012

View the Baltimore Sun Notice


U.S. Supreme Court Petitioned to Review AMP et al. Lawsuit on Gene Patents

December 13, 2011
View the full Press Release

AMP Opposes Exclusive Licensing of NIH Proteomics Patent

November 22, 2011
View the full Press Release

AMP Responds to Proposed HHS Human Research Protections Rule
October 24, 2011
View Comments to HHS (PDF)

AMP Mourns the Loss of Dr. William A. Gardner
October 5, 2011
Read the notice by AMP Executive Officer Emeritus, Dr. Mark Sobel (PDF)

Current Issue of the AMP Newsletter
October 2011 Newsletter
Read Past AMP Newsletters

AMP Urges Congress to Maintain Funding for Graduate Medical Education
September 20, 2011
Read the letter (PDF)

AMP Responds to FDA RUO/IUO FAQ's
August 30, 2011
View the full Press Release (PDF) View Comments to the FDA (PDF)

Divided Appeals Court Rules that Breast Cancer Genes May be Patented but Invalidates Methods Patents
July 29, 2011
Read the Ruling (PDF). View the full Press Release (PDF).

AMP Appoints Mary Steele Williams to Position of Executive Director

June 30, 2011
View the full Press Release (PDF).

AMP Opposes Wasserman-Schultz Gene Patent Amendments
June 20, 2011
Read the Letter to the House Judiciary Committee (PDF)

AMP Comments at FDA Meeting on Next Generation Sequencing
June 23, 2011
View full Press Release (PDF). View Comments to the FDA (PDF).

June 2011 Issue of the AMP Newsletter
June 2011 Newsletter

AMP Releases Statement on Diagnostics in Drug Labels
May 16, 2011
View full Press Release (PDF).

JMD Online Access - Login Required
View login instructions. (PDF)

AMP will Engage NCCN Regarding Molecular Tests

Oral Argument in Gene Patent Case
April 4, 2011
An audio recording of the argument is available online. (Search for Appeal Number 2010-1406).

AMA Releases a New Coding System for Molecular Pathology
March 10, 2011
Proposal for CPT Coding Reform for Molecular Diagnostics.

February 2011 Issue of the AMP Newsletter

Read the February 2011 Newsletter

AMP moves to Managed Publishing for JMD
January, 2011
Read the Elsevier Journal Transition Information

AMP Comments to FDA Regarding Draft Guidance on Detection of C. difficile

February 28, 2011
Download the statement


October 2010 Issue of the AMP Newsletter
Read the October 2010 Newsletter

Lab Coalition Sends Second Letter to FDA Regarding LDTs
October 6, 2010
Download the Letter

AMP Commends the SACGHS on a Job Well Done and Provides Comments Regarding Whole Genome Sequencing
October 5, 2010
Dowload the statement

Lab Coalition Encourages FDA to Continue Interaction Regarding Oversight of LDTs

September 15, 2010
Download Letter

AMP Responds to Genetic Test Registry Request for Information
July 29, 2010
Download Entire Press Release Download full statement

AMP Presents at FDA Meeting on Regulating Diagnostics

July 20, 2010
Download Entire Press Release Download full statement

AMP Comments to FDA Regarding Regulation of Cytogenetic Arrays
June 30, 2010
Download statement

Comments to FDA CDRH Council Regarding Barriers to Market for Molecular Diagnostic Tests June 30, 2012

Download Statement

Comments to SACGHS Regarding the Draft Report on Genetics Education and Training
June 30, 2010
Download Statement

AMP Commends SACGHS's Whole Genome Sequencing Focus, Raises Ethical Questions and Forms Whole Genome Analysis Working Group
June 15, 2010

Download statement

AMP Cautions Consumers About Direct Access Genetic Testing

May 14, 2010
Download Entire Press Release

The Association for Molecular Pathology Celebrates Ruling in DNA Patent Case
March 31, 2010
Download Entire Press Release